Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
AREDS supports the use of nutritional supplements for AMD
Fort Lauderdale, FL-Of the nearly 60 million people in the United States over age 55, 8 million are estimated to be at high risk for advanced age-related macular degeneration (AMD), making it an important public health concern. However, nutritional supplements may be helpful to reduce this risk, according to the Age-Related Eye Disease Study (AREDS).
Related Videos
Related Content
